What is generic semaglutide?
Semaglutide is the active ingredient in Ozempic®, which is prescribed for the management of type 2 diabetes, and Wegovy®, which is prescribed for weight management. Until recently, these brand-name medications were the only options available in Canada.
In April 2026, Health Canada authorized the first generic version of semaglutide making Canada the first G7 country to approve a generic form of this medication. Generic semaglutide contains the same active ingredient and must meet the same standards for safety, efficacy, and quality as the brand-name products.
For many Canadians, the availability of generic semaglutide means lower out-of-pocket costs as they are often priced at least 50% lower than the brand-name equivalent.
If you're currently taking Ozempic® or Wegovy®, or if you've been considering semaglutide, speak with your pharmacist. They can help you understand your options and what switching to a generic — if appropriate for you — might mean for your treatment and your costs.